Form 4: Clorox Director Stephanie Plaines Reports Acquisition of Deferred Stock Units

Director Stephanie Plaines reports acquisition of deferred stock units in The Clorox Company through dividend reinvestment and in lieu of quarterly director's fees.

Summary

• Stephanie Plaines, a director of The Clorox Company, filed a Form 4 on April 02, 2024, reporting changes in beneficial ownership.
• The report details the acquisition of deferred stock units (DSUs) through dividend reinvestment on February 09, 2024, and in lieu of quarterly director's fees on March 28, 2024.
• On February 9, 2024, 22.5566 Deferred Stock Units were acquired through dividend reinvestment.
• On March 28, 2024, 171.4454 Deferred Stock Units were acquired in lieu of quarterly director's fees.
• These DSUs will be settled 100% in Clorox stock upon the director's retirement or termination of service.
• Following these transactions, Plaines beneficially owns 3,073.7279 deferred stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The director is increasing their stake in the company, which can be seen as a positive signal. However, it's a routine transaction related to compensation.

Positives

• The acquisition of deferred stock units demonstrates the director's continued investment in the company's future.
• Dividend reinvestment indicates confidence in the company's performance and dividend policy.

Future Outlook

The director's holdings will increase over time through continued dividend reinvestments and director's fees, further aligning their interests with those of shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Director compensation in the form of stock and deferred stock units is a common practice among publicly traded companies, including Clorox's peers such as Procter & Gamble (PG) and Unilever (UL), to align management's interests with shareholder value.
• The specific amounts and terms of these compensation packages vary based on company size, performance, and industry norms.
• The reporting of these transactions via Form 4 is a standard regulatory requirement, ensuring transparency and preventing insider trading.

Stakeholder Impact

• The increased holdings of a director can positively influence shareholder confidence.
• The use of deferred stock units aligns the director's interests with long-term shareholder value.

Key Dates